quantisnow
FeedTopReportsPricing
⌘K
Live feed
09:10:00·1101d
PRRelease
Deluxe Corporation logo
iClick Interactive Asia Group Limited logo
Ideanomics Inc. logo
+3

Spruce Point Capital Management Announces Investment Opinion: Releases Report and Strong Sell Research Opinion on Nuvei Corp. (NASDAQ: NVEI / TSX: NVEI)

DLX· Deluxe CorporationICLK· iClick Interactive Asia Group LimitedIDEX· Ideanomics Inc.NVEI· Nuvei Corporation Subordinate Voting SharesPAYA· Paya Holdings Inc.FTAC· FinTech Acquisition Corp. III
Consumer DiscretionaryTechnologyFinance
Original source

Companies

  • DLX
    Deluxe Corporation
    Consumer Discretionary
  • ICLK
    iClick Interactive Asia Group Limited
    Technology
  • IDEX
    Ideanomics Inc.
    Consumer Discretionary
  • NVEI
    Nuvei Corporation Subordinate Voting Shares
    Consumer Discretionary
  • PAYA
    Paya Holdings Inc.
    Technology
  • FTAC
    FinTech Acquisition Corp. III
    Finance

Recent analyst ratings

  • May 8NVEIUpdateJP Morgan$34.00
  • Apr 19DLXUpdateNorthcoast$27.00
  • Jan 17NVEIUpdateWells Fargo$29.00
  • Dec 20NVEIUpdateBarclays$34.00
  • Dec 5NVEIUpdateBMO Capital Markets$30.00
  • Nov 30NVEIUpdateSeaport Research Partners$25.00

Related

  • PR2d
    Deluxe to Report First Quarter 2026 Results on May 6, 2026
  • PR15d
    Deluxe Merchant Services Announces New Financial Institution Partnership with Washington Trust Bank
  • SEC20d
    SEC Form DEFR14A filed by Deluxe Corporation
  • INSIDER37d
    Director Yancy Telisa L acquired 0 shares (SEC Form 4)
  • INSIDER37d
    Director Brown Angela L was granted 1,036 shares, increasing direct ownership by 8% to 13,505 units (SEC Form 4)
  • INSIDER37d
    Director Cummins Hugh S. Iii was granted 1,036 shares (SEC Form 4)
  • SEC45d
    SEC Form DEFA14A filed by Deluxe Corporation
  • SEC45d
    SEC Form DEF 14A filed by Deluxe Corporation
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022